Navigation Links
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Date:5/14/2008


* Philip Beachy, Ph.D., Stanford University Institute for Stem Cell

Biology and Regenerative Medicine and HHMI, has pioneered the use of

synthetic small molecules and natural products to manipulate activities

of developmental and stem cell signaling pathways in vitro and in vivo.

* Sheng Ding, Ph.D., Scripps Research Institute, has worked on the

identification of small molecules and genes that control cell fate,

including cell reprogramming and differentiation. Dr. Ding's work has

important implications for the development of small molecule drugs that

can potentiate adult stem cells in vivo, and reprogram differentiated

cells to new functions.

* Randall Moon, Ph.D., University of Washington; Director, Institute for

Stem Cell and Regenerative Medicine; HHMI; and UW Department of

Pharmacology, has focused on illuminating the biological pathways that

control adult stem cells during the process of regeneration to develop

new therapeutic methods to activate regeneration.

* David Scadden, M.D., Professor, Harvard University; Co-Director and

Co-Founder, Harvard Stem Cell Institute; Director, Massachusetts

General Hospital Center for Regenerative Medicine, has broken new

ground in understanding how blood forming stem cells and other adult

stem cells are maintained in the adult body in specialized niches, and

in developing therapies that exploit this biology to modulate adult

stem cells in vivo.

* Leonard Zon, M.D., Harvard University; Director of the Stem Cell

Program, Children's Hospital of Boston; and HHMI, is a world expert on

the biology of adult blood forming stem cells and methods of enhancing

their function for cancer and regenerative medicine applications.

Formed in early 2007, Fate Therapeutics raised $15 million in its Series A fin
'/>"/>

SOURCE Fate Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
2. Amicus Therapeutics Announces First Quarter 2008 Financial Results
3. Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
4. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
5. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
6. TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast
7. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
8. President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year
9. NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
10. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
11. Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBCs 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... (PRWEB) December 22, 2014 Fertility Associates ... Donor Egg Bank USA , a network of more ... Through this partnership, patients have fast access to a ... vitro fertilization, IVF . Fertility Associates of Memphis is ... this fertility treatment option. , Dr. William Kutteh ...
(Date:12/19/2014)... December 19, 2014 Charm Sciences is ... for the Detection of Aflatoxin M1 in raw commingled ... independent third party validation. The peer reviewed report of ... the Institute for Agricultural and Fisheries Research (ILVO-T&V) has ... , Aflatoxin B1, the most toxic aflatoxin and a ...
(Date:12/19/2014)... Naurex Inc., a biopharmaceutical company leveraging its ... the central nervous system, today announced that Norbert ... present at the 33 rd annual J.P. Morgan ... 3:00 p.m. PST on Tuesday, January 13, 2015, at ... Calif. About Naurex Inc. ...
(Date:12/19/2014)... REDWOOD CITY, Calif. , Dec. 19, 2014 ... , USA) announced today that they have been ... Technologies 1,2 is a privately held company that ... processing of next generation sequencing (NGS) data for the ... into the Roche Sequencing Unit, and will continue to ...
Breaking Biology Technology:Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... to tight integration and ... excellent value, ... a,leader in radiology and medical image and information management solutions,today announced ... 100 facilities that use MEDITECH(TM) as their health,information system. AMICAS will ...
... May 27 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), ... announced that the,Ministry of Health has purchased approximately ... hepatitis A vaccine, Healive(R), to,vaccinate people living in ... has delivered shipments of the Healive vaccine to,Sichuan, ...
... Calif., May 27 Epitomics, Inc., the rabbit,monoclonal ... its,1000th new rabbit monoclonal antibody. Each antibody has ... proprietary rabbit monoclonal,antibody technology. "We are very excited ... of time. This demonstrated the robustness of our ...
Cached Biology Technology:AMICAS Announces Integrations at More Than 100 MEDITECH Facilities 2AMICAS Announces Integrations at More Than 100 MEDITECH Facilities 3Sinovac Receives RMB 20 Million Purchase Order for Healive from China's Ministry of Health to Vaccinate Earthquake Victims 2Epitomics Announces the Creation of 1000th Rabbit Monoclonal Antibody 2
(Date:12/10/2014)... 2014 You,ve been here before: you desperately need ... your password, site key or the answer to your secret ... teacher? Today, Hoyos Labs , a ... will finally put an end to the frustration that comes ... . 1U leverages a user,s smartphone to acquire his or ...
(Date:12/10/2014)... , December 9, 2014 ... BCARD Platform   ... meeting scheduling solutions for business-to-business (B2B) events, today ... leader in mobile near-field communication (NFC), Bluetooth low ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will ...
(Date:12/3/2014)... 2014 As part of our commitment to ... pleased to announce the release of a new reader ... the workforce data that they need. The ... by existing readers. Many such devices have serious shortcomings ... technology. Older models force users to navigate numerous complicated ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2
... enzyme Akt1 could provide the key to boosting the ... dendritic cells, the immune-system master switches that promote the ... Baylor College of Medicine in a report that appears ... issue of the journal Nature Biotechnology. , "By keeping ...
... de Investigaciones Científicas (CSIC) has discovered a new route ... discovery that will enable the biotechnological design of plant ... produce oral vaccines which, upon being ingested, will be ... the door to the design of protein-manufacturing plants of ...
... Bioinformatics Institute and Duke University Medical Center have ... an important role in the development and virulence ... fungal pathogen that causes black spot disease on ... leaf loss in many economically important crops including ...
Cached Biology News:'Super' enzyme may lead way to better tumor vaccines 2Vaccine-producing 'plant-factories' 2Tearing down the fungal cell wall 2Tearing down the fungal cell wall 3
Request Info...
This buffer is Specifically formulated to be used with Endogen's Poly-HRP Streptavidin...
... Fujifilm Life Science FLA-7000 excels at fluorescent ... gel documentation. It features four easy-to-access filters ... a filter for Imaging Plates) for upgrading ... customizable choice of four kinds of excitation ...
... The Microarray Gene Frame® has ... hybridisations. These frames feature the same ... standard Gene Frame® range for easy ... hybridisation uniformity and there are three ...
Biology Products: